In:
Cancer, Wiley, Vol. 126, No. 24 ( 2020-12-15), p. 5256-5262
Abstract:
Hyperthermic intraperitoneal chemotherapy does not increase perioperative complications and does not affect a patient's recovery or time to start adjuvant chemotherapy. Hyperthermic intraperitoneal chemotherapy should be offered to select patients listed for interval debulking surgery.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v126.24
Language:
English
Publisher:
Wiley
Publication Date:
2020
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1
Permalink